Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Blood Cancer Journal|April 24, 2024
RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectivesDana Alawieh, Leila Cysique-Foinlan, Christophe Willekens, et al.
Journal of Blood Medicine|September 14, 2016
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectivesJohanna Mondesir, Christophe Willekens, Mehdi Touat, et al.
Journal of Medical Case Reports|July 5, 2011
Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case reportChristophe Willekens, Aurélie Cornelius, Mary-Jane Guerry, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer CampusAli N Chamseddine, Christophe Willekens, Stephane De Botton, et al.
Expert Review of Hematology|October 29, 2014
Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factorsNicolas Duployez, Christophe Willekens, Alice Marceau-Renaut, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 1, 2017
Is the Precautionary Principle Really Incoherent?Thomas Boyer-Kassem
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 14, 2017
The Precautionary Principle Has Not Been Shown to Be Incoherent: A Reply to PetersonThomas Boyer-Kassem
Frontiers in Oncology|September 7, 2021
Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?Romane Joudinaud, Thomas Boyer
Hemoglobin|July 21, 2010
Identification of a new mutation on the beta-globin gene: codons 8/9 (+AGAA); GAG.AAG.TCT(Glu-Lys-Ser)>GAG. AAAGAAG, in a patient from the north of France with a phenotype of beta-thalassemia minorAnne France Georgel, Claude Méreau, Christophe Willekens, et al.
Rheumatology (Oxford, England)|November 9, 2020
Low dose IL-2 in patients with steroid-dependent dysimmune manifestations associated with myelodysplastic syndromes: a three-case reportMarion Corfmat, Christophe Willekens, Julien Vinit, et al.
Pageof 9